And it's simple to use... And it's simple to use... Millions of lives could be saved by this brand-new bio invention that detects over 50 cancers. You are receiving this email because you subscribed to Longevity Insider HQ.
[Click here]( to manage your e-mail preferences.
[Longevity Insider HQ logo] Bio Invention Catches Cancers That Often Fly Under the Radar! Anil Bajnath, MD | November 08, 2021 | Baltimore, MD Dear Longevity Insider, Anil Bajnath MD here with your Monday roundup. As some people age, they get hesitant about going to the doctor’s. Some are overtaken by a fear of the unknown. “What if I’m sick? What if I have cancer? I’d rather not know at all.”Many would prefer to live their life in a bubble until it’s too late. You’ve heard the term, “Ignorance is bliss.” Science says otherwise, especially when it comes to cancer.Could you imagine finding out that you have stage 3 cancer that could have been identified (and treated) a year prior?Imagine the pain and agony that would inflict on all of your loved ones. Imagine all of the years you could be missing out on with family vacations, spending time with your grandchildren and great grandchildren.You have too much at stake to be lackadaisical with your health, with your longevity. Cancer is expected to soon be the leading cause of death in the U.S. in 2021. So here’s a fascinating test you can’t afford to be oblivious about. Meet Galleri™. It’s [a multi-cancer early cancer detection test](. It can detect more than 50 types of cancers through an easy blood draw. Minetta Liu, MD, an oncologist at Mayo Clinic, played a huge role in the development of Galleri. She too is excited about this ground-breaking invention: Today, many cancers are found too late, leading to poor outcomes. The ability to detect cancer early is critical to successful treatment. Even more to consider, the recommended cancer screening tests only cover five cancer types, while screening for one type of cancer at a time.The problem is that 71% of cancer deaths are caused by the other remaining cancers that people are diagnosed with. So there’s much need for the Galleri.Performing as Promised Scientists used the test in the Circulating Cell-Free Genome Atlas (CCGA) Study. And the test performed just as promised: - More than 50 types of cancer were detected.
- Low false-positive rate of less than 1%.
- Pinpoints where in the body the cancer is located. Dr. Josh Ofman, Chief Medical Officer and Head of External Affairs at GRAIL, offers his gratitude: We are grateful to Mayo Clinic for its dedication to advancing new technologies for early cancer detection and for playing a pivotal role in the development of Galleri. A simple blood test capable of detecting more than 50 cancers is a ground-breaking advancement and could have a tremendous human and economic benefit. This is truly a day of celebration in the world of science, health, and longevity. The sooner we catch signs of complications, the better! [Researchers have also linked many age-related diseases to a naturally occurring process in your body. And here's a science-backed method for approaching this dilemma...]( To your longevity, Anil Bajnath MD
CEO/Founder, Institute for Human Optimization
Chief Medical Officer, Longevity Insider HQ --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here](, and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Longevity Insider HQ, please add newsletter@longevityinsiderhq.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. Longevity Insider HQ, Copyright © 2021. All rights reserved. 3 E. Read Street, Baltimore, MD 21202. For customer service, call (844) 491-5756. The content of this site may not be redistributed without the express written consent of Longevity Insider HQ. Individual editorials, articles and essays appearing on this site may be republished, but only with full attribution of both the author and Longevity Insider HQ as well as a link the website. None of these statements have been approved by the FDA to diagnose or treat any disease. Always consult with a trusted medical professional before starting or changing a health regimen. [Full Disclaimer](